Find Grants for Higher Education
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-298
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.839, 93.173, 93.279, 93.840, 93.273, 93.395, 93.855, 93.865, 93.233, 93.853, 93.361, 93.121, 93.393, 93.172, 93.399, 93.866, 93.846, 93.837, 93.838, 93.396, 93.351, 93.394, 93.242, 93.213, 93.867, 93.113, 93.286
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-239
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: November 5, 2027
Opportunity Number: PAR-25-297
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.866
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Deadline: March 20, 2026
Opportunity Number: PAR-25-242
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: March 20, 2026
Status: Posted
CFDA Numbers: 93.313, 93.173, 93.865, 93.989, 93.242, 93.399, 93.853, 93.286, 93.867
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-310
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-251
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-134
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855, 93.233, 93.213, 93.121, 93.399, 93.853, 93.396, 93.395, 93.273, 93.879, 93.846, 93.847, 93.242, 93.286, 93.113, 93.361, 93.279, 93.394, 93.839, 93.837, 93.838, 93.173, 93.393, 93.859, 93.172, 93.840, 93.310, 93.866, 93.867, 93.865
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-215
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Deadline: November 12, 2027
Opportunity Number: PAR-25-216
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-265
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-270
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-269
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-271
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-188
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-300
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Alcohol Health Services Research (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PA-25-245
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Health Services Research (R34 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-192
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Deadline: September 7, 2026
Opportunity Number: PA-25-163
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Deadline: September 7, 2026
Opportunity Number: PAR-25-193
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
